Hide on Homepage

On Friday, January 10th, leading cancer research experts convened for a workshop focused on Solving the Early Detection and Diagnosis of Recalcitrant Cancers. The event, jointly hosted by the Lustgarten […]

UNIONDALE, N.Y., January 9, 2025 — The Lustgarten Foundation announced a new grant today, awarded to Nina Steele, PhD, and Howard Crawford, PhD, of the Henry Ford Pancreatic Cancer Center […]

WATCH – Get the latest insights into groundbreaking advancements and the exciting road ahead in pancreatic cancer research.

Dr. David Slavin In September 2017, Dr. David Slavin, then a 54-year-old Chiropractor from Long Island, started experiencing stomach pain and just didn’t feel right, and he feared the worst. […]

It is with a heavy heart that we remember the life of valiant Lustgarten Foundation advocate, friend, and honorary chairman of our Corporate Advisory Board, President Jimmy Carter, 39th President […]

It is with profound sadness that we honor the life and legacy of Charles Dolan, Co-founder and Chairman Emeritus of the Lustgarten Foundation, following his passing on Saturday, December 28th, […]

Break Through Cancer has launched a collaborative cohort for a Phase 1 study of RMC-6236, a compound developed by Revolution Medicines that is designed to suppress multiple RAS proteins that […]

Learn how our LABS (Lustgarten Advancing Breakthrough Science) program fosters collaboration and accelerates breakthroughs in research from three of our six internationally renowned Lustgarten lab leaders — Tyler Jacks, PhD, […]